Imugene Ltd News

Imugene Ltd: Updated Appendix 3Z

Nov 20 02:25 ET

Imugene Ltd: Final Director's Interest Notice

Nov 20 01:13 ET

Imugene Ltd: Director Resignation

Nov 14 16:23 ET

Imugene Ltd: Imugene 2024 AGM Results

Nov 13 21:59 ET

Imugene Ltd: Imugene AGM Presentation

Nov 13 16:24 ET

Imugene Ltd: onCARlytics Trial Doses First Patient in IT Combination Arm

Nov 10 17:03 ET

Imugene Ltd: Imugene Opens First Australian Site for azer-cel Trial

Nov 7 18:08 ET

Imugene Ltd: Complete Response in MAST Study Maintained Over Two Years

Nov 4 17:04 ET

Imugene Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Oct 30 18:10 ET

Imugene Ltd: Notification regarding unquoted securities - IMU

Oct 14 01:40 ET

Imugene Ltd: Notification of cessation of securities - IMU

Oct 14 01:37 ET

Imugene Ltd: Application for quotation of securities - IMU

Oct 14 01:36 ET

Imugene Ltd: Notice of Annual General Meeting/Proxy Form

Oct 14 01:28 ET

Imugene Ltd: Change of Director's Interest Notice - PH

Sep 30 03:01 ET

Imugene Ltd: Imugene Receives Orphan Drug Designation for VAXINIA

Sep 17 23:06 ET

Imugene Ltd: Appendix 2A

Sep 11 02:59 ET

Imugene Ltd: Imugene Corporate Presentation

Sep 8 20:12 ET

Imugene Ltd: Cleansing Notice

Sep 4 02:32 ET

Imugene Ltd: Application for quotation of securities - IMU

Sep 4 02:29 ET

Imugene Ltd: Imugene Azer-cel Webinar Presentation

Sep 3 20:19 ET